基本信息
浏览量:134
职业迁徙
个人简介
In short CCIT comprise clinical and experimental expertise in tumor immunology. The Centre has approx. 25 employees; scientists, clinicians, PhD students, as well as technicians. The Centre has extensive experience in initiating clinical trials in cancer, and more than 100 cancer patients have been vaccinated with dendritic cell based therapeutic vaccinations and new facilities for GCP production of cellular products for clinical use was recently opened, enabling trials using adoptive cell transfer of tumor specific T cells. Currently 5 trials are active (www.clinicaltrial.gov), including patients with both solid and hematological malignancies. Concerning experimental cancer research the laboratory is equipped with state of the art instruments for flow cytometry (eg. 2 FACSAria and one LSR-II instrument), cell culture, PCR, in house construction of recombinant proteins (HLA molecules), DNA and RNA transfections, serum analyses, ect. Main experimental contributions have been made in characterization of tumor antigens recognized by CD8 T cells, studies of T cell biology, cancer genetics, dendritic cell biology, regulatory T cells, and biological monitoring of therapeutic vaccination trials, ect.
CCIT has an international profile with an extensive network with scientists and clinicians in European and the US. CCIT are founding members of European Society for Cancer Immunology and Immunotherapy, and Nordic “Network for anti-tumor vaccination” NCEV: www.cck.ki.se/ncev. Moreover, CCIT are active members of the European “Cancer Immunotherapy (C-IMTC) Monitoring Group”, focusing on standardization of biological monitoring of clinical trials using biological modifiers.
CCIT has an international profile with an extensive network with scientists and clinicians in European and the US. CCIT are founding members of European Society for Cancer Immunology and Immunotherapy, and Nordic “Network for anti-tumor vaccination” NCEV: www.cck.ki.se/ncev. Moreover, CCIT are active members of the European “Cancer Immunotherapy (C-IMTC) Monitoring Group”, focusing on standardization of biological monitoring of clinical trials using biological modifiers.
研究兴趣
论文共 316 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Methods in molecular biology (Clifton, N.J.) (2024): 29-39
Hannah Jorinde Glockner,Evelina Martinenaite,Thomas Landkildehus Lisle,Jacob Grauslund, Shamaila Ahmad,Oezcan Met,Per Thor Straten,Mads Hald Andersen
ONCOIMMUNOLOGYno. 1 (2024): 2318053-2318053
Asha M Rudjord-Levann,Zilu Ye, Lise Hafkenscheid, Sabrina Horn, Renske Wiegertjes,Mathias A I Nielsen,Ming Song,Caroline B K Mathiesen, Jesse Stoop,Sean Stowell,Per Thor Straten,Hakon Leffler,
引用0浏览0WOS引用
0
0
crossref(2023)
crossref(2023)
crossref(2023)
Per thor Straten,Cécile Gouttefangeas,Juliane Schuhmacher, Sara Fresnillo Saló, Anne Rahbech, Sara Pedersen
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn